Analysis of immune infiltration suggests that LST1-mediated efferocytosis may influence ccRCC susceptibility or disease progression by sustaining immune signaling activation and disrupting regulatory balance, potentially stemming from early inflammation in T2DM. This evidence concerns the gene LST1 and nonpapillary renal cell carcinoma.